190 related articles for article (PubMed ID: 20888137)
1. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).
Neben-Wittich MA; Atherton PJ; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Loprinzi CL; Burger KN; Martenson JA; Miller RC
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):397-402. PubMed ID: 20888137
[TBL] [Abstract][Full Text] [Related]
2. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
3. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).
Atherton PJ; Burger KN; Loprinzi CL; Neben Wittich MA; Miller RC; Jatoi A; Sloan JA
Support Care Cancer; 2012 Aug; 20(8):1729-35. PubMed ID: 21922203
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
5. Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).
Sio TT; Atherton PJ; Birckhead BJ; Schwartz DJ; Sloan JA; Seisler DK; Martenson JA; Loprinzi CL; Griffin PC; Morton RF; Anders JC; Stoffel TJ; Haselow RE; Mowat RB; Wittich MA; Bearden JD; Miller RC
Support Care Cancer; 2016 Sep; 24(9):3847-55. PubMed ID: 27075674
[TBL] [Abstract][Full Text] [Related]
6. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
7. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
8. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.
Hindley A; Zain Z; Wood L; Whitehead A; Sanneh A; Barber D; Hornsby R
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):748-55. PubMed ID: 25585779
[TBL] [Abstract][Full Text] [Related]
9. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
Boström A; Lindman H; Swartling C; Berne B; Bergh J
Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
[TBL] [Abstract][Full Text] [Related]
10. Topical agents for radiation dermatitis in breast cancer: 50 shades of red or same old, same old?
Freedman GM
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):736-8. PubMed ID: 25585778
[No Abstract] [Full Text] [Related]
11. Comparing Dermolina-Henna Cream with Mometasone Cream in Improving Radiodermatitis Among Patients with Breast Cancer: A Randomized Active-Control Double-Blind Clinical Trial.
Pasalar M; Ahadi B; Mirzaei HR; Buentzel J; Mehri Ardestani M; Kamian S; Heydarirad G
J Integr Complement Med; 2022 Nov; 28(11):895-903. PubMed ID: 36103288
[No Abstract] [Full Text] [Related]
12. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.
Chan RJ; Mann J; Tripcony L; Keller J; Cheuk R; Blades R; Keogh S; Poole C; Walsh C
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):756-64. PubMed ID: 25151541
[TBL] [Abstract][Full Text] [Related]
13. Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis.
Koo JY; Martin D
Int J Dermatol; 2001 Mar; 40(3):210-2. PubMed ID: 11422529
[No Abstract] [Full Text] [Related]
14. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
[TBL] [Abstract][Full Text] [Related]
15. RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements.
Huang CJ; Hou MF; Luo KH; Wei SY; Huang MY; Su SJ; Kuo HY; Yuan SS; Chen GS; Hu SC; Chuang HY
Breast; 2015 Jun; 24(3):230-6. PubMed ID: 25777626
[TBL] [Abstract][Full Text] [Related]
16. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
17. [Interest of a sterilised anti-burning gel in radiation dermatitis: results of a comparative study].
Ribet V; Salas S; Levecq JM; Bastit L; Alfonsi M; De Rauglaudre G; Talon B; Allavena C; Miot C; Boisseau JM; Faure P
Ann Dermatol Venereol; 2008 Jan; Spec No 1():5-10. PubMed ID: 18342111
[TBL] [Abstract][Full Text] [Related]
18. 3M Cavilon No-Sting Barrier Film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: A clinical trial.
Shaw SZ; Nien HH; Wu CJ; Lui LT; Su JF; Lang CH
J Formos Med Assoc; 2015 May; 114(5):407-14. PubMed ID: 23685085
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]